AzTrials
AzTrials

PtsdNCT05938816

Feasibility and Acceptability of Stress Induction, Physiological Data Collection, and Mindfulness-Based Stress Reduction Among Combat Veterans With PTSD

A study testing Mindfulness-Based Stress Reduction (MBSR) and Health and Wellness Education (HWE) in people with Ptsd, run by Oregon Health and Science University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Investigators will recruit up to 20 veterans with PTSD. Participants will be randomized into two conditions: MBSR and Health and Wellness Education (HWE; control group). Participants will be randomized at a 1:1 ratio. Purpose of the study is to learn how mindfulness meditation may be helpful in treating PTSD. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Ptsd
What is being tested?
Mindfulness-Based Stress Reduction (MBSR) and Health and Wellness Education (HWE)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
7 participants
Where
1 siteUnited States
Study dates
7 Jul 2023to 3 Feb 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult (18-85yo)
  • Military veteran
  • Experiencing PTSD symptoms
  • Reading and speaking in English
  • Be able to travel to OHSU for three two-hour lab visits, 8 weekly intervention sessions and one long extended session, and a two- hour focus group

Who cannot join

  • Pregnancy
  • Severe untreated depression, cognitive impairment, or active suicidality*
  • Life-threatening or severely disabling medical conditions
  • Excessive use of alcohol, nicotine, or cannabis

Trial locations and contacts

1 site in 1 country.

United States1 site
  • OHSU

    Portland, Oregon, 97239

Other trials in United States

About this study

Investigators will recruit up to 20 veterans with PTSD. Participants will be randomized into two conditions: MBSR and Health and Wellness Education (HWE; control group). Participants will be randomized at a 1:1 ratio. Purpose of the study is to learn how mindfulness meditation may be helpful in treating PTSD. Participants will undergo 2 screening sessions, 8 weekly sessions of intervention (MBSR or HWE), 3 laboratory visits that will include completing survey questionnaires, stress test and recording of heart rate, blood pressure and breathing rate.

Conditions
Ptsd
Being tested
Mindfulness-Based Stress Reduction (MBSR), Health and Wellness Education (HWE)
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-Based Stress Reduction (MBSR)Behavioural

    MBSR consists of weekly two-hour sessions for eight weeks, and a 7.5 hour retreat between weeks 6 and 7. The MBSR intervention will be facilitated by an experienced and certified MBSR teacher. MBSR curriculum strongly encourages completion of home practice assignments (~30 minutes daily) to help integration of concepts into daily life. Participants will receive audio CDs and a DVD to help guide home practice.

  • Health and Wellness Education (HWE)Behavioural

    HWE is a didactic-based group intervention designed as an active comparator for randomized-controlled trials of MBSR. HWE provides instruction to participants regarding improving their emotional and physical health. In contrast to MBSR, there are no attempts to train participants' breathing, movement, or meditation habits or practices. HWE is administered in 8 weekly 2.5-hour classes with home practice to be completed between sessions (matched to MBSR for amount and effort). HWE also features one extended 7.5-hour retreat, similar to MBSR.84 Dr. Autumn Gallegos (consultant) has conducted trials of MBSR among veterans with PTSD using a HWE control group, and will provide mentorship to the PI in administering the HWE intervention. Dr. Kaplan and a trained RA will facilitate HWE.

Study groups in NCT05938816
Study groupRoleWhat they receive
Mindfulness-Based Stress ReductionExperimentalNot described
Receives: Behavioral: Mindfulness-Based Stress Reduction (MBSR)
Health and Wellness EducationPlacebo comparatorNot described
Receives: Behavioral: Health and Wellness Education (HWE)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Qualitative Interview Targeting Feasibility of MBSR

    Qualitative data generated via focus group interviews. Questions will include common barriers to completing the intervention and strategies utilized by participants to maximize adherence.

    Measured: 2 weeks post conclusion of intervention

  2. Qualitative Interview Targeting Acceptability of MBSR

    Qualitative data generated via focus group interviews. Questions will include ratings of the relevance of the content presented to participants' lives, as well as assessment of the method of presentation.

    Measured: 2 weeks post conclusion of intervention. Data were not collected due to prematurely study closure due to PI change of career.

Secondary outcomes (5)
  1. Psychological Resilience 1

    Measured by self-report measure: Brief Resilience Scale (BRS). Scale ranges from 1-5 and higher scores indicate higher psychological resilience.

    Measured: Pre (week 0), mid (week 4), and post intervention (week 10). Data were not collected due to prematurely study closure due to PI change of career.

  2. Blood Pressure Reactivity

    Reactivity of physiological parameters (e.g., systolic and diastolic blood pressure) to a cognitive stress task.

    Measured: Pre (week 0), mid (week 4), and post intervention (week 10).

  3. PTSD Symptoms 1

    Measured by a self-report questionnaire: the PTSD Symptom Checklist (PCL). Scores range from 0-4 and higher scores indicate more severe PTSD symptoms.

    Measured: Pre (week 0), mid (week 4), and post intervention (week 10).

  4. Psychological Resilience 2

    Measured by self-report measure: Connor-Davidson Resilience Scale (CD-RISC). Scores range from 0-4 and higher scores indicate higher psychological resilience.

    Measured: Pre (week 0), mid (week 4), and post intervention (week 10).

  5. PTSD Symptoms

    Measured a clinician-administered semi-structured interview: the Clinician-Administered PTSD Scale (CAPS-5). Symptoms are rated for severity (0-absent; 1-mild/subthreshold; 2-moderate/threshold; 3-severe/markedly elevated; 4-extreme/incapacitating) and the presence of distress (minimal; clearly present; pronounced; extreme). Symptom clusters are also rated for the likelihood that they are related to the index trauma (definite; probable; unlikely).

    Measured: Pre (week 0), mid (week 4), and post intervention (week 10).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2023
  2. Study start7 Jul 2023
  3. Primary completion28 Nov 2023
  4. Study completion3 Feb 2024

Why it stopped: PI change of career

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05938816
Sponsor's protocol ID
STUDY00025508
Other IDs
KL2TR002370
Status last verified
Oct 2024
First submitted
7 Jun 2023
Last updated
5 Nov 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-Based Stress Reduction (MBSR) and Health and Wellness Education (HWE) in people with Ptsd, run by Oregon Health and Science University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 5 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 5 Nov 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Qualitative Interview Targeting Feasibility of MBSR (time frame: 2 weeks post conclusion of intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in